Read More...Clinical benefit of FEES for initiation of PO intake during and after radiotherapy for Head and Neck Cancer">
Site Overlay

Clinical benefit of FEES for initiation of PO intake during and after radiotherapy for Head and Neck Cancer


Authors: Loughnane H,Malherbe K
Publication: Journal of The Irish Head and Neck Society - 2023
Issue: 1 Volume: 1
Published: June, 2023 View PDF

Approximately one-third of patients receiving head and neck chemoradiotherapy develop pneumonia requiring treatment. If aspiration pneumonia is suspected, nil per oral may be recommended. However, this would compromise neuroplasticity and long-term patient outcomes.

We present 3 cases with different sites of lesion, receiving neoadjuvant chemoradiotherapy with curative intent. These patients required admission for management of radiotherapy side–effects including odynophagia, RTIs and weight loss.

Fibreoptic Endoscopic Evaluation of Swallow (FEES) was used frequently to objectively assess swallow physiology, efficiency and safety. This facilitated MDT decisions for earlier initiation of oral intake, maintaining swallowing function and optimizing quality of life.

Tell us what went wrong - include any error codes & a screenshot if possible
Upload a screenshot if you have it
Accepted file types: jpg, gif, png, pdf, heic, doc, docx, Max. file size: 50 MB.
This field is for validation purposes and should be left unchanged.

This will close in 0 seconds